Surgalign Holdings, Inc.
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 78.12M | 81.98M | 83.24M | 83.60M | 87.81M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 78.12M | 81.98M | 83.24M | 83.60M | 87.81M |
| Cost of Revenue | 26.03M | 26.19M | 25.52M | 26.82M | 28.03M |
| Gross Profit | 52.09M | 55.79M | 57.72M | 56.79M | 59.79M |
| SG&A Expenses | 91.70M | 95.89M | 98.66M | 102.37M | 103.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -898.00K | -898.00K | -3.93M | -3.93M | -3.93M |
| Total Operating Expenses | 131.02M | 136.92M | 137.57M | 141.61M | 143.17M |
| Operating Income | -52.90M | -54.94M | -54.34M | -58.01M | -55.36M |
| Income Before Tax | -51.56M | -55.65M | -103.91M | -103.67M | -108.63M |
| Income Tax Expenses | -1.07M | -1.04M | 410.00K | -932.00K | -943.00K |
| Earnings from Continuing Operations | -50.49 | -54.61 | -104.32 | -102.74 | -107.69 |
| Earnings from Discontinued Operations | -- | -- | 1.56M | 1.91M | -3.64M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 41.90M | 41.90M | 41.90M |
| Net Income | -50.49M | -54.61M | -60.86M | -58.93M | -69.43M |
| EBIT | -52.90M | -54.94M | -54.34M | -58.01M | -55.36M |
| EBITDA | -50.78M | -52.75M | -51.98M | -55.50M | -52.84M |
| EPS Basic | -7.57 | -8.08 | -12.13 | -12.39 | -15.78 |
| Normalized Basic EPS | -3.02 | -3.08 | 5.29 | 5.42 | 4.63 |
| EPS Diluted | -8.12 | -8.08 | -12.14 | -12.40 | -15.79 |
| Normalized Diluted EPS | -2.78 | -3.06 | 5.31 | 5.44 | 4.65 |
| Average Basic Shares Outstanding | 28.23M | 25.89M | 23.73M | 21.60M | 18.77M |
| Average Diluted Shares Outstanding | 33.48M | 26.07M | 23.91M | 21.78M | 18.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |